LEADER 02967oam 2200661I 450 001 9910792787203321 005 20190503073434.0 010 $a0-262-33735-5 010 $a0-262-33734-7 035 $a(CKB)3710000001078666 035 $a(MiAaPQ)EBC4837496 035 $a(CaBNVSL)mat07904024 035 $a(IDAMS)0b00006485c8c132 035 $a(IEEE)7904024 035 $a(OCoLC)981764916$z(OCoLC)991108121$z(OCoLC)993085500$z(OCoLC)1001270577$z(OCoLC)1001543989 035 $a(OCoLC-P)981764916 035 $a(MaCbMITP)10771 035 $a(Au-PeEL)EBL4837496 035 $a(CaPaEBR)ebr11370987 035 $a(OCoLC)981764916 035 $a(PPN)255693419 035 $a(EXLCZ)993710000001078666 100 $a20170406d2017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aGiving voice $emobile communication, disability, and inequality /$fMeryl Alper 210 1$aCambridge, MA :$cMIT Press,$d[2017] 210 4$dİ2017 215 $a1 online resource (288 pages) $cillustrations 225 1 $aThe John D. and Catherine T. MacArthur Foundation series on digital media and learning 311 $a0-262-03558-8 311 $a0-262-53397-9 320 $aIncludes bibliographical references and index. 327 $aIntroduction -- Talking iPads and the partial promise of voice -- What is voice? -- Making a case for iPad cases -- What is a mobile communication device? -- The "fun iPad" and the "communication iPad" -- What is an iPad for? -- Augmenting communication with new media and popular culture -- What does it mean to communicate with an iPad? -- "You've gotta be plugged in" -- How do media shape understandings of the iPad? -- Conclusions. 330 $aHow communication technologies meant to empower people with speech disorders -- to give voice to the voiceless -- are still subject to disempowering structural inequalities. 410 0$aThe John D. and Catherine T. MacArthur Foundation series on digital media and learning 606 $aCommunication devices for people with disabilities$xSocial aspects 606 $aVoice output communication aids$xSocial aspects 606 $aAssistive computer technology$xSocial aspects 606 $aSociology of disability 610 $aDIGITAL HUMANITIES & NEW MEDIA/General 610 $aINFORMATION SCIENCE/Communications & Telecommunications 610 $aSOCIAL SCIENCES/Communications 615 0$aCommunication devices for people with disabilities$xSocial aspects. 615 0$aVoice output communication aids$xSocial aspects. 615 0$aAssistive computer technology$xSocial aspects. 615 0$aSociology of disability. 676 $a362.4/0483 700 $aAlper$b Meryl$0846174 801 0$bOCoLC-P 801 1$bOCoLC-P 906 $aBOOK 912 $a9910792787203321 996 $aGiving voice$93723633 997 $aUNINA LEADER 03552nam 22006735 450 001 9910300096803321 005 20251117071625.0 010 $a1-4471-5472-X 024 7 $a10.1007/978-1-4471-5472-3 035 $a(CKB)3710000000073724 035 $a(EBL)1592860 035 $a(SSID)ssj0001067244 035 $a(PQKBManifestationID)11612776 035 $a(PQKBTitleCode)TC0001067244 035 $a(PQKBWorkID)11097044 035 $a(PQKB)10554283 035 $a(MiAaPQ)EBC1592860 035 $a(DE-He213)978-1-4471-5472-3 035 $a(PPN)176096949 035 $a(EXLCZ)993710000000073724 100 $a20131121d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCardiac Drugs in Pregnancy /$fedited by Karen Sliwa, John Anthony 205 $a1st ed. 2014. 210 1$aLondon :$cSpringer London :$cImprint: Springer,$d2014. 215 $a1 online resource (141 p.) 225 1 $aCurrent Cardiovascular Therapy 300 $aDescription based upon print version of record. 311 08$a1-4471-5471-1 327 $aIntroduction -- General principles and guidelines -- Management of Hypertension -- Management of Heart Failure -- Management of  coronary artery disease & Arrhythmia -- Anticoagulation in Pregnancy -- Obstetric drugs in management if Cardiovascular disease -- Pregnancy anaesthesia in patients with cardiovascular disease. 330 $aIn the western world, the risk of cardiovascular disease in pregnancy has grown due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading to early diabetes and hypertension. As a result more women are requiring drug therapy during pregnancy  and some data has shown an altered pharmacodynamic profile in pregnant women when compared to the non-pregnant population. Cardiac Drugs in Pregnancy presents up-to-date research for the treatment of cardiovascular disease during pregnancy, and  discusses the most important indications of drug usage in pregnancy and postpartum. The book aims to assess the potential risk of drugs and their possible benefit against each other, making it an essential read for a wide range of health professionals involved in cardiac drug therapy in pregnancy. 410 0$aCurrent Cardiovascular Therapy 606 $aCardiology 606 $aObstetrics 606 $aMaternal and child health services 606 $aChemotherapy 606 $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037 606 $aObstetrics/Perinatology/Midwifery$3https://scigraph.springernature.com/ontologies/product-market-codes/H26014 606 $aMaternal and Child Health$3https://scigraph.springernature.com/ontologies/product-market-codes/H27025 606 $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000 615 0$aCardiology. 615 0$aObstetrics. 615 0$aMaternal and child health services. 615 0$aChemotherapy. 615 14$aCardiology. 615 24$aObstetrics/Perinatology/Midwifery. 615 24$aMaternal and Child Health. 615 24$aPharmacotherapy. 676 $a616.1061 702 $aSliwa$b Karen$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aAnthony$b John$c(Professor of obstetrics and gynecology)$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300096803321 996 $aCardiac Drugs in Pregnancy$91522055 997 $aUNINA